ASH Research Collaborative News
An innovative study of patients with multiple myeloma rapidly accrued a diverse cohort, demonstrated high consent/adherence rates, and assessed COVID-19 outcomes and their impact on quality of life. The research was presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, California, and online.
The ASH Research Collaborative (ASH RC) Data Hub, which was developed to facilitate research and quality improvement through real-world data, accurately correlates sickle cell disease (SCD) genotype with verified diagnoses, validating existing and future clinical data in the ASH RC’s Data Hub, according to new research presented today at the 66th ASH Annual Meeting and Exposition.
Presentations highlight how real-world data accelerate research and improve hematology care.
The ASH Research Collaborative (ASH RC) Data Hub’s Multiple Myeloma Program can feasibly collect patient data from its participating sites for prospective evidence generation, according to new research presented at the 66th ASH Annual Meeting and Exposition.
The ASH Research Collaborative® (ASH RC) is proud to announce its Board of Directors, a diverse group of hematologists and data, health systems, and informatics experts committed to advancing critical research and accelerating positive change for people living with hematologic conditions.
The American Society of Hematology and the ASH RC are happy to announce the launch of the Pilot Sickle Cell Disease Learning Community. The Sickle Cell Disease Learning Community is focused on improving the care and outcomes of people living with Sickle Cell Disease through the adoption of evidence informed best practices.
The Office of Minority Health (OMH) at the U.S. Department of Health and Human Services (HHS) announced today an approximately $1,000,000 grant to the American Society of Hematology (ASH) to develop and implement a national sickle cell disease (SCD) clinical data collection platform.
ASH Clinical News recently covered the launch of the ASH RC Data Hub COVID-19 Registry.
The Data Hub’s Oversight Group Chair, Dr. William Wood, was recently interviewed by the ASCO Post about the ASH RC Data Hub COVID-19 Registry for Hematologic Malignancy.
The ASH Research Collaborative’s Data Hub COVID-19 Registry for Hematologic Malignancy was recently covered in Healio.
